Literature DB >> 10022840

Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.

A L Brass1, A Q Zhu, H Singh.   

Abstract

Gene expression in higher eukaryotes appears to be regulated by specific combinations of transcription factors binding to regulatory sequences. The Ets factor PU.1 and the IRF protein Pip (IRF-4) represent a pair of interacting transcription factors implicated in regulating B cell-specific gene expression. Pip is recruited to its binding site on DNA by phosphorylated PU.1. PU.1-Pip interaction is shown to be template directed and involves two distinct protein-protein interaction surfaces: (i) the ets and IRF DNA-binding domains; and (ii) the phosphorylated PEST region of PU.1 and a lysine-requiring putative alpha-helix in Pip. Thus, a coordinated set of protein-protein and protein-DNA contacts are essential for PU.1-Pip ternary complex assembly. To analyze the function of these factors in vivo, we engineered chimeric repressors containing the ets and IRF DNA-binding domains connected by a flexible POU domain linker. When stably expressed, the wild-type fused dimer strongly repressed the expression of a rearranged immunoglobulin lambda gene, thereby establishing the functional importance of PU.1-Pip complexes in B cell gene expression. Comparative analysis of the wild-type dimer with a series of mutant dimers distinguished a gene regulated by PU.1 and Pip from one regulated by PU.1 alone. This strategy should prove generally useful in analyzing the function of interacting transcription factors in vivo, and for identifying novel genes regulated by such complexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022840      PMCID: PMC1171190          DOI: 10.1093/emboj/18.4.977

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element.

Authors:  S Dalton; R Treisman
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

2.  An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes.

Authors:  P H Driggers; D L Ennist; S L Gleason; W H Mak; M S Marks; B Z Levi; J R Flanagan; E Appella; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B.

Authors:  J Hagman; C M Rudin; D Haasch; D Chaplin; U Storb
Journal:  Genes Dev       Date:  1990-06       Impact factor: 11.361

4.  Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors.

Authors:  C M Rudin; U Storb
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

5.  PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.

Authors:  J M Pongubala; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

6.  A two-step mechanism for recruitment of Pip by PU.1.

Authors:  J M Perkel; M L Atchison
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

7.  A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells.

Authors:  M M Müller; S Ruppert; W Schaffner; P Matthias
Journal:  Nature       Date:  1988-12-08       Impact factor: 49.962

8.  Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function.

Authors:  H W Mittrücker; T Matsuyama; A Grossman; T M Kündig; J Potter; A Shahinian; A Wakeham; B Patterson; P S Ohashi; T W Mak
Journal:  Science       Date:  1997-01-24       Impact factor: 47.728

9.  Nuclear factor of activated T cells contains Fos and Jun.

Authors:  J Jain; P G McCaffrey; V E Valge-Archer; A Rao
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

10.  Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo.

Authors:  M G Wathelet; C H Lin; B S Parekh; L V Ronco; P M Howley; T Maniatis
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

View more
  62 in total

1.  Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter.

Authors:  Luciano De Haro; Ralf Janknecht
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

2.  Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain.

Authors:  Soumya G Remesh; Vishaka Santosh; Carlos R Escalante
Journal:  J Biol Chem       Date:  2015-09-24       Impact factor: 5.157

3.  Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages.

Authors:  Leopoldo Laricchia-Robbio; Tomohiko Tamura; Tatiana Karpova; Brian L Sprague; James G McNally; Keiko Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-23       Impact factor: 11.205

4.  An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia.

Authors:  Mathew A Cherian; Sydney Olson; Hemalatha Sundaramoorthi; Kitra Cates; Xiaogang Cheng; John Harding; Andrew Martens; Grant A Challen; Manoj Tyagi; Lee Ratner; Daniel Rauch
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

5.  IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development.

Authors:  Runqing Lu; Kay L Medina; David W Lancki; Harinder Singh
Journal:  Genes Dev       Date:  2003-06-27       Impact factor: 11.361

6.  Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts.

Authors:  Sujatha Nagulapalli; Aisha Goheer; Leslie Pitt; Lawrence P McIntosh; Michael L Atchison
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

7.  A role for interferon regulatory factor 4 in receptor editing.

Authors:  Simanta Pathak; Shibin Ma; Long Trinh; Runqing Lu
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

Review 8.  Epigenomics of macrophages.

Authors:  David Gosselin; Christopher K Glass
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

Review 9.  IRF4: Immunity. Malignancy! Therapy?

Authors:  Arthur L Shaffer; N C Tolga Emre; Paul B Romesser; Louis M Staudt
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

10.  Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4.

Authors:  Kyoko Ochiai; Mark Maienschein-Cline; Giorgia Simonetti; Jianjun Chen; Rebecca Rosenthal; Robert Brink; Anita S Chong; Ulf Klein; Aaron R Dinner; Harinder Singh; Roger Sciammas
Journal:  Immunity       Date:  2013-05-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.